Pure Global AI
NCT06324422Recruiting

Exercise as Treatment of Fatigue in Parkinson´s Disease

Can High-intensity Exercise be Used to Treat Fatigue in Parkinson´s Disease?
University of AarhusClinicalTrials.govother
Verified
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
Aerobic exercise intervention
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Aarhus
Location
Aarhus, Denmark
Timeline & enrollment
Phase
N/A
Start date
Apr 24, 2024
End date
Dec 01, 2026
Enrollment
94 participants
Primary outcome

Change in Modified Fatigue Impact Scale

Summary

The primary goal of this study is to test whether 12 weeks of high-intensity aerobic exercise
 can treat fatigue in Parkinsons disease (PD).
 
 The study will be a randomized multi-site controlled trial with follow up. Clinically
 fatigued persons with PD will be allocated to either 12 weeks of high-intensity aerobic
 exercise or to a waitlist control group receiving high-intensity resistance exercise after 24
 weeks of habitual lifestyle (control period).
 
 It is hypothesized that persons with PD receiving 12 weeks of high-intensity aerobic exercise
 will show superior effects on perceived fatigue (i.e., clinical relevant reductions) when
 compared to the PD control group (primary hypothesis), and that these effects are sustained
 after 12-weeks of follow up (secondary hypothesis).

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06324422
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06324422 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Aarhus and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 94 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.